发明名称 MATERIALS AND METHODS FOR MANAGEMENT OF HYPERACUTE REJECTION IN HUMAN XENOTRANSPLANTATION
摘要 Human pre-formed xenoantibodies play an important role in the hyperacute rejection response in human xenotransplantation. Disclosed are materials and methods for removing or neutralizing such antibodies. Also disclosed are materials and methods for reducing or eliminating the epitopes in the donor organs that are recognized by such antibodies. Such epitopes are formed as the result of activity by the enzyme alpha -1,3 galactosyltransferase. The porcine gene encoding alpha -1,3 galactosyltransferase is disclosed, as are materials and methods for inactivating ("knocking out") the alpha -1,3 galactosyltransferase gene in mammalian cells and embryos. Included are nucleic acid constructs useful for inactivating the alpha -1,3 galactosyltransferase gene in a target cell. Also disclosed is a novel leukemia inhibitory factor (T-LIF) that is useful for maintenance of embryonic stem cells and primordial germ cells in culture.
申请公布号 EP0755451(A4) 申请公布日期 1997.11.26
申请号 EP19950907116 申请日期 1995.01.27
申请人 BRESAGEN LIMITED;ST. VINCENT'S HOSPITAL (MELBOURNE) LIMITED 发明人 PEARSE, MARTIN J.;CRAWFORD, ROBERT J.;ROBBINS, ALLAN J.;RATHJEN, PETER D.;D'APICE, ANTHONY J.F.
分类号 A01K67/027;A61K31/70;A61K38/00;C07K1/22;C07K14/47;C07K14/54;C07K16/40;C07K16/44;C12N5/10;C12N9/10;C12N15/09;C12N15/54;C12N15/85 主分类号 A01K67/027
代理机构 代理人
主权项
地址